News

scale money prices shopping transparency reimbursement dollar coins

Negotiated professional prices for hospital-based radiology services are about 43% higher than independents vs. 16% more for PE-backed rad groups.

doors subspecialty specialize

Experts with Indiana University are urging peers to understand the motivations behind expansion and focus on cultural compatibility. 

Outpatients treated at the Mayo Clinic saw a nearly 78% drop in the median time it took to access their radiology reports, falling from about 4.9 hours down to 1.1 after the Cures Act.

stomach gastrointestinal digestive

Despite its high accuracy, CTA can come with tradeoffs including requiring radiologists to review a high number of images looking for findings that can be subtle, increasing case complexity and workloads. 

Umar Mahmood, MD, PhD

Umar Mahmood, MD, PhD, currently is chief of nuclear medicine and molecular imaging at Massachusetts General Hospital and a Harvard professor of radiology, will take on the title beginning Feb. 1. 

 

the words "FDA recall" on a board

The Class 2 recall pertains to the system's built-in shielding and collimation accessories. 

Thumbnail

Leqembi (lecanemab) was approved by the FDA in 2023. It is an infusion drug that has been shown to reduce Alzheimer’s-related cognitive decline by up to 27%. 

UnitedHealthcare

Rad Partners "firmly" denied the allegations, which mirror a similar complaint from Aetna, contending it plans to "vigorously defend against these claims" in court. 

Neko Health founders

Neko Health was first launched in 2018 and has experienced “overwhelming demand” since then, with long wait lists for its service.

MDView lets individuals upload medical images to its platform and connect with independent, subspecialized physicians for a fresh take on their results. 

Icometrix said the current procedural terminology code covers its FDA-cleared quantification software, “creating a path to reimbursement.” 

Thumbnail

When matched by gender and career length, nonemergency rads are nearly twice as likely to be promoted to associate professor. 

Around the web

The Class 2 recall pertains to the system's built-in shielding and collimation accessories. 

Leqembi (lecanemab) was approved by the FDA in 2023. It is an infusion drug that has been shown to reduce Alzheimer’s-related cognitive decline by up to 27%. 

Chatbots may be able to accurately explain MRI results to patients in ways that radiologists are not routinely available to do.